HAVCR2 (TIM-3) as a favorable prognostic immune marker in seminoma: Integrative checkpoint screening and tissue validation
- DOI
- 10.1016/j.ctarc.2026.101278
- Published
- 2026
- Container
- Cancer Treatment and Research Communications
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ctarc.2026.101278,
title = {HAVCR2 (TIM-3) as a favorable prognostic immune marker in seminoma: Integrative checkpoint screening and tissue validation},
author = {Ki Hong Kim and Dae Young Lee and Hee Jo Yang and Si Hyun Kim and Doo Sang Kim and Chang Ho Lee and Soon Auck Hong and Byung Hoon Chi and Ji-Hye Lee and Youn Soo Jeon},
year = {2026},
journal = {Cancer Treatment and Research Communications},
doi = {10.1016/j.ctarc.2026.101278},
url = {https://doi.org/10.1016/j.ctarc.2026.101278}
}RIS
TY - JOUR TI - HAVCR2 (TIM-3) as a favorable prognostic immune marker in seminoma: Integrative checkpoint screening and tissue validation AU - Ki Hong Kim AU - Dae Young Lee AU - Hee Jo Yang AU - Si Hyun Kim AU - Doo Sang Kim AU - Chang Ho Lee AU - Soon Auck Hong AU - Byung Hoon Chi AU - Ji-Hye Lee AU - Youn Soo Jeon PY - 2026 JO - Cancer Treatment and Research Communications DO - 10.1016/j.ctarc.2026.101278 UR - https://doi.org/10.1016/j.ctarc.2026.101278 ER -
APA
Kim, K. H., Lee, D. Y., Yang, H. J., Kim, S. H., Kim, D. S., Lee, C. H., Hong, S. A., Chi, B. H., Lee, J., & Jeon, Y. S. (2026). HAVCR2 (TIM-3) as a favorable prognostic immune marker in seminoma: Integrative checkpoint screening and tissue validation. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2026.101278
Source records
- crossref · retrieved 2026-09-27T07:02:16.365Z